PTSM: Pharmaceutical Technology Sourcing and Management, Apr 6, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Apr 6, 2011
APIs
The Changing Players and Supply Base for Generic Drugs
By Patricia Van Arnum
Increased competition, the rising role of emerging markets, and targeted opportunities in niche segments are factors influencing the generic-drug market and related supply base.
Outsourcing
A First Hand Look at India's Pharma Services Sector
By Jim Miller
Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.
Supply Chain
Navigating the Supply Chain in Fine Chemicals
By Patricia Van Arnum
Chemspec USA, which will be held in early May, in Philadelphia, addresses the key issues affecting the manufacturing and supply of fine chemicals.
CSR and Sustainability Forum
Manufacturing and Access in Public Health, Government, and Developing World Markets
By Chan Harjivan , Diana Elkis
This article, which focuses on manufacturing and drug access, is Part II of a three-part series on biopharmaceutical issues in public health, government, and developing world markets.
Technology Transfer in Global Health Initiatives
By Patricia Van Arnum
Eli Lilly and GlaxoSmithKline are among several pharmaceutical companies using technology transfer as way to improve health outcomes in the developing world.
Leaders from Business, Government and NGOs Advance Solutions for the Developing World
By Patricia Van Arnum
The Women in the World Summit, which was held in New York in March, focused on issues and solutions for improving the economic, political, and social rights of women globally, including a focus on global health initiatives.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here